Abstract
The 2014 WHO classification distinguishes between endometrial hyperplasia without atypia (EH) and atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (AEH/EIN). AEH/EIN is characterized by crowded glands with cytologically atypical epithelium separated by little intervening stroma. Cellular atypia is characterized by nuclear enlargement and rounding, pleomorphism, loss of polarity, and presence of nucleoli. The diagnosis of atypia is facilitated by comparison with areas of adjacent normal and non-atypical glands, respectively. AEH/EIN is often associated with squamous but also secretory and mucinous metaplasia. Loss of PTEN and/or PAX2 immunoreactivity occurs in up to two thirds of AEH/EIN. In contrast, invasive low-grade endometrioid carcinoma shows confluent growth with loss of stroma and formation of labyrinth-like or cribriform structures. Differential diagnosis includes different forms of metaplasias, papillary proliferations, and hyperplastic polyps. Epithelial metaplasia may be present in various benign endometrial lesions as well as in endometrioid adenocarcinoma. AEH/EIN may also occur in endometrial polyps. Progestin therapy of AEH/EIN has low level of evidence but frequently leads to complete regression. Serous intraepithelial carcinoma (SEIC) is characterized by high-grade cellular atypia and polymorphism, detachment of cells, amutant immunoreactive pattern for the P53 and anincreased Ki67 labeling index. Although designated as precursor of serous carcinoma of the endometrium, biologically it is considered a non-invasive serous carcinoma since it may already be associated with massive extrauterine spread.
Highlights
Abb. 7 9 Differenzialdiagnostisch zu beachten sind die zytologisch blande Tubenepithelmetaplasie, hier in einem unregelmäßig sekretorisch transformierten Endometrium (a) und die papilläre synzytiale Metaplasie (b), jeweils bei vorzeitiger Abstoßung
Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ (2014) Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy
Summary
Der Großteil der Endometriumkarzinome, im speziellen die endometrioiden Karzinome und seine Varianten, entwickelt sich über eine definierte Vorstufe, die atypische Endometriumhyperplasie, die wiederum auf dem Boden einer Endometriumhyperplasie ohne Atypien entsteht [1]. Die WHO hat 2014 die Klassifikation der Präneoplasien des endometrioiden Endometriumkarzinoms durch die Reduktion auf 2 Kategorien wesentlich vereinfacht [2]. Eine Gegenüberstellung mit der WHO-Klassifikation 2003 und der traditionellen deutschsprachigen Einteilung nach Frau Prof. Dallenbach-Hellweg [3] findet sich in. Tab. 1, wobei es eine Überschneidung zwischen den einzelnen Untergruppen gibt
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
